Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase III, Randomized, Placebo-controlled, Parallel Group, Double-blind Study to Evaluate the Efficacy and Safety of NIO752 in Participants With Progressive Supranuclear Palsy Followed by an Open Label Extension

This Phase III study is intended to evaluate the efficacy and safety of NIO752 in participants with Progressive Supranuclear Palsy (PSP). Eligible participants…

Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)

Novartis PharmaceuticalsNCT07498426